Free Trial

Viridian Therapeutics (VRDN) SEC Filings & 10K Form

Viridian Therapeutics logo
$12.80 -0.50 (-3.76%)
Closing price 04/15/2025 04:00 PM Eastern
Extended Trading
$12.62 -0.18 (-1.41%)
As of 08:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Viridian Therapeutics SEC Filings

DateFilerForm TypeView
04/11/2025
4:15 PM
COMMODORE CAPITAL LP (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SCHEDULE 13G
04/09/2025
3:19 PM
Ajer Jeffrey Robert (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/09/2025
3:26 PM
Ajer Jeffrey Robert (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2025
6:12 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2025
3:27 PM
Tripuraneni Radhika (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/12/2025
3:36 PM
Tripuraneni Radhika (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
3:17 PM
CAIN CHRISTOPHER W. (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/12/2025
3:19 PM
CAIN CHRISTOPHER W. (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
8:12 PM
Harmon Seth (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
8:13 PM
Beetham Thomas W. (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
8:14 PM
Mahoney Stephen F. (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
8:17 PM
Tousignant Jennifer (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
5:09 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 424B5
03/03/2025
3:35 PM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/03/2025
6:33 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/27/2025
6:11 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
5:05 PM
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SCHEDULE 13G/A
12/16/2024
6:22 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
4:52 PM
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SC 13G/A
11/14/2024
4:53 PM
Venrock Opportunities Fund, L.P. (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SC 13G/A
11/14/2024
3:50 PM
PERCEPTIVE ADVISORS LLC (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SC 13G/A
11/14/2024
3:33 PM
Paradigm Biocapital Advisors LP (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SC 13G/A
11/12/2024
6:15 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
6:15 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/18/2024
11:33 AM
STATE STREET CORP (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SC 13G/A
09/30/2024
6:12 PM
Beetham Thomas W. (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
6:10 PM
Mahoney Stephen F. (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
8:00 PM
Fairmount Funds Management LLC (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SC 13D/A
09/17/2024
8:00 PM
Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Fund II GP LLC (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
5:07 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 424B5
09/12/2024
4:25 PM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2024
3:28 PM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 424B5
09/10/2024
6:11 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
7:25 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
7:01 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/15/2024
5:31 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2024
3:25 PM
Gheuens Sarah (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:16 PM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2024
7:05 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form DEFA14A
05/08/2024
6:51 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2024
6:09 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Trump’s betrayal exposed (Ad)

Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you ready for it?

Click here to find out how to survive “Trump’s Reset”
04/26/2024
7:30 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form DEF 14A
04/26/2024
7:30 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form DEF 14A
04/26/2024
7:32 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form DEFA14A
04/26/2024
7:32 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form DEFA14A
04/26/2024
7:34 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form ARS
04/26/2024
7:34 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form ARS
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:VRDN) was last updated on 4/16/2025 by MarketBeat.com Staff
From Our Partners